Stock Scorecard
Stock Summary for Viatris Inc (VTRS) - $11.25 as of 4/22/2024 10:50:56 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for VTRS
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for VTRS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for VTRS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for VTRS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for VTRS
Financial Details for VTRS
Company Overview |
|
|---|---|
| Ticker | VTRS |
| Company Name | Viatris Inc |
| Country | USA |
| Description | Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/6/2024 |
Stock Price History |
|
| Last Day Price | 11.25 |
| Last Day Price Updated | 4/22/2024 10:50:56 PM EST |
| Last Day Volume | 5,099,330 |
| Average Daily Volume | 7,263,297 |
| 52-Week High | 13.48 |
| 52-Week Low | 8.53 |
| Last Price to 52 Week Low | 31.89% |
Valuation Measures |
|
| Trailing PE | 225.00 |
| Industry PE | 99.84 |
| Sector PE | 60.50 |
| 5-Year Average PE | 2.53 |
| Free Cash Flow Ratio | 12.93 |
| Industry Free Cash Flow Ratio | 12.59 |
| Sector Free Cash Flow Ratio | 29.99 |
| Current Ratio Most Recent Quarter | 1.67 |
| Total Cash Per Share | 0.87 |
| Book Value Per Share Most Recent Quarter | 17.05 |
| Price to Book Ratio | 0.66 |
| Industry Price to Book Ratio | 5.66 |
| Sector Price to Book Ratio | 22.08 |
| Price to Sales Ratio Twelve Trailing Months | 0.87 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
| Total Shares Outstanding | 1,187,570,000 |
| Market Capitalization | 13,360,162,500 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 3/8/2024 |
| Last Dividend Amount | 0.12 |
| Current Dividend Amount | 0.12 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.48 |
| Trailing Annual Dividend Yield | 4.27% |
| Forward Annual Dividend Rate | 0.57 |
| Forward Annual Dividend Yield | 5.07% |
| 5-Year Dividend Payments Count | 12 |
| 3-Year Average Dividend Yield | 3.73% |
| 5-Year Average Dividend Yield | 3.73% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 20.60% |
| 5-Year Dividend Growth Rate Percentage | 18.92% |
| All-Time Dividend Growth Rate Percentage | 20.88% |
| Dividend Payout Ratio | 960.00% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -6.90% |
| Annual Earnings Growth | -97.37% |
| Reported EPS 12 Trailing Months | 0.05 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 2.93 |
| Net Income Twelve Trailing Months | 54,700,000 |
| Net Income Past Year | 54,700,000 |
| Net Income Prior Year | 2,078,600,000 |
| Quarterly Revenue Growth YOY | -1.00% |
| 5-Year Revenue Growth | 7.62% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,028,900,000 |
| Total Cash Past Year | 1,028,900,000 |
| Total Cash Prior Year | 1,295,200,000 |
| Net Cash Position Most Recent Quarter | -34,199,100,000 |
| Net Cash Position Past Year | -34,199,100,000 |
| Long Term Debt Past Year | 35,228,000,000 |
| Long Term Debt Prior Year | 37,428,000,000 |
| Total Debt Most Recent Quarter | 35,228,000,000 |
| Equity to Debt Ratio Past Year | 0.37 |
| Equity to Debt Ratio Most Recent Quarter | 0.37 |
| Total Stockholder Equity Past Year | 20,467,400,000 |
| Total Stockholder Equity Prior Year | 21,072,300,000 |
| Total Stockholder Equity Most Recent Quarter | 20,467,400,000 |
Options |
|
| Put/Call Ratio | 0.19 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.20 |
| MACD Signal | -0.13 |
| 20-Day Bollinger Lower Band | 9.90 |
| 20-Day Bollinger Middle Band | 11.60 |
| 20-Day Bollinger Upper Band | 13.30 |
| Beta | 1.15 |
| RSI | 32.55 |
| 50-Day SMA | 10.35 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 4/20/2024 2:03:51 PM EST |